Patent · US Active

Antibodies specifically binding to human IL-1R7

US11352432B2 · kind B2 · utility

0Cited by

0References

15Claims

0Family size

Assignee

MAB Discovery GmbH · DE

Inventors

Stephan Fischer · Weilheim, DE
Karsten BECKMANN · Albany, US

Key dates

Filing date	Mar 9, 2018
Grant date	Jun 7, 2022
Priority date	—
Expiry date	Mar 9, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/71
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to monoclonal antibodies that specifically bind to human IL-1 R7, or a fragment or derivative thereof or a polypeptide that contain at least a portion of said antibody that is sufficient to confer specific IL-1 R7 binding to the polypeptide. The invention also relates to the use of said antibodies in the treatment of a IL-18 mediated disease and pharmaceutical compositions comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of the antibody according to the invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.